BioLife Solutions, Inc.: income tax expense or benefit
Income tax expense or benefit for BioLife Solutions, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All BioLife Solutions, Inc. financial histories
What this measure means
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
Exact concept: us-gaap:IncomeTaxExpenseBenefit. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2012-01-01 to 2025-12-31. The SEC response was captured on 2026-09-19.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 49,000 | USD | 2026-02-26 | 10-K · 0001628280-26-012294 |
| 2024-01-01 | 2024-12-31 | -38,000 | USD | 2026-02-26 | 10-K · 0001628280-26-012294 |
| 2023-01-01 | 2023-12-31 | -64,000 | USD | 2026-02-26 | 10-K · 0001628280-26-012294 |
| 2022-01-01 | 2022-12-31 | -5,236,000 | USD | 2025-03-03 | 10-K · 0001628280-25-009511 |
| 2021-01-01 | 2021-12-31 | -20,118,000 | USD | 2024-02-29 | 10-K · 0001628280-24-008061 |
| 2020-01-01 | 2020-12-31 | -3,264,000 | USD | 2023-03-31 | 10-K · 0001437749-23-008875 |
| 2019-01-01 | 2019-12-31 | -1,541,000 | USD | 2022-03-31 | 10-K · 0001437749-22-007869 |
| 2017-01-01 | 2017-12-31 | 0 | USD | 2018-03-09 | 10-K · 0001144204-18-013727 |
| 2016-01-01 | 2016-12-31 | 0 | USD | 2018-03-09 | 10-K · 0001144204-18-013727 |
| 2015-01-01 | 2015-12-31 | 0 | USD | 2017-03-15 | 10-K · 0001144204-17-014799 |
| 2014-01-01 | 2014-12-31 | 0 | USD | 2016-02-25 | 10-K · 0001354488-16-006364 |
| 2013-01-01 | 2013-12-31 | 0 | USD | 2015-03-12 | 10-K · 0001354488-15-001113 |
| 2012-01-01 | 2012-12-31 | 0 | USD | 2014-02-12 | 10-K · 0001354488-14-000653 |
Related financial histories
- BioLife Solutions, Inc.: total assets
- BioLife Solutions, Inc.: total liabilities
- BioLife Solutions, Inc.: stockholders equity
- BioLife Solutions, Inc.: cash and cash equivalents
- BioLife Solutions, Inc.: net income or loss
- BioLife Solutions, Inc.: operating cash flow
- BioLife Solutions, Inc.: capital expenditure payments
- BioLife Solutions, Inc.: financing cash flow
- BioLife Solutions, Inc.: investing cash flow
- BioLife Solutions, Inc.: retained earnings or deficit
- BioLife Solutions, Inc.: basic weighted-average shares
- BioLife Solutions, Inc.: diluted weighted-average shares
- BioLife Solutions, Inc.: basic earnings per share
- BioLife Solutions, Inc.: diluted earnings per share
- BioLife Solutions, Inc.: net property, plant and equipment
- BioLife Solutions, Inc.: share-based compensation expense
- BioLife Solutions, Inc.: operating income or loss
- BioLife Solutions, Inc.: current assets
- BioLife Solutions, Inc.: interest expense
- BioLife Solutions, Inc.: current liabilities
- BioLife Solutions, Inc.: current accounts payable
- BioLife Solutions, Inc.: goodwill carrying amount
- BioLife Solutions, Inc.: net finite-lived intangible assets
- BioLife Solutions, Inc.: net current accounts receivable
- BioLife Solutions, Inc.: operating expenses
- BioLife Solutions, Inc.: net inventory
- BioLife Solutions, Inc.: gross profit
- BioLife Solutions, Inc.: cost of revenue
- BioLife Solutions, Inc.: research and development expense
Inspect the source
- Entity
- BioLife Solutions, Inc. / CIK 0000834365
- Captured
- 2026-09-19T15:08:45.571Z
- SEC response SHA-256
cc2cf8f92622e29fea17afa7805fcf370f2d2caa2d36b6cf780e7beb9e287e2f
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000834365.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))